CD1C and nonpapillary renal cell carcinoma: Although there have been no reports associating CD1C or CYP51A1 gene mutations with the survival of PRCC patients, a previous study on CCRCC patients has reported that high expression of CD1C gene is associated with higher survival rates (p < 0.0001) [32].